NOTABLE LABS, LTD. Bankruptcy Filing

NOTABLE LABS, LTD. Filing Information

NOTABLE LABS, LTD., a California-based corporation, has filed for Chapter 7 bankruptcy protection with the United States Bankruptcy Court for the District of Delaware. The company's bankruptcy filing, which occurred on October 13, 2024, marks a significant development in its financial restructuring efforts. According to publicly available information, NOTABLE LABS, LTD. is seeking relief under Chapter 7 of the Bankruptcy Code, which allows for the liquidation of assets and the distribution of proceeds to creditors. The court case number assigned to this filing is 24-12336. The company's bankruptcy filings reveal a significant shift in its organizational structure, as it seeks to reorganize its financial obligations and navigate an uncertain future.

NOTABLE LABS, LTD., a company specializing in pharmaceutical and medicine manufacturing, has filed for bankruptcy. The filing, which marks the beginning of a tumultuous chapter for the business, reveals an uncertain financial future. According to the court documents, NOTABLE LABS' assets are valued at between $0 and $100,000, a stark contrast to its liability range of $1 million to $10 million. This disparity indicates that the company's debts far outweigh its assets, suggesting a significant cash flow problem. The bankruptcy filing also reveals that NOTABLE LABS is facing an extensive number of creditors, underscoring the complexity and magnitude of the financial challenges it now faces. With this move, the pharmaceutical manufacturing firm will be subject to court supervision as it navigates the complex process of reorganization or liquidation.

NOTABLE LABS, LTD. indicated on its bankruptcy petition that it does not expect there will be sufficient assets in the estate to make a payment to the unsecured creditors.